Skip to content
Dosage GuideResearch Reference

Taltirelin Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Taltirelin. All information is for educational purposes only.

Quick Answer

Taltirelin is typically administered orally at a dosage of 5 mg twice daily for the treatment of spinocerebellar degeneration, based on approved usage in Japan. Dosage adjustments may be necessary based on individual response and tolerance. No human clinical dose-ranging trials have been completed outside of the approved dosage.

→ Taltirelin Benefits→ Taltirelin Side Effects→ Full Taltirelin Profile
Table of Contents

Standard Dosage Range

Research dosing range: 5 mg twice daily (oral)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Spinocerebellar Degeneration (SCD)

5 mg2× daily
Duration

Ongoing

Approved dosage for SCD in Japan. Taken orally as a tablet. Monitor for improvements in ataxia symptoms. Should be taken regularly to maintain optimal effects.

Cerebellar Ataxia

5 mg2× daily
Duration

Ongoing

Used off-label for other types of cerebellar ataxia with similar dosing regimen as SCD. Effectiveness may vary depending on the specific cause of ataxia.

Cognitive Enhancement (Experimental)

2.5 - 5 mg1-2x daily
Duration

4-12 weeks

Used experimentally for cognitive enhancement. Dosage is often lower initially to assess tolerability. Evidence is preliminary and based on TRH analogue effects.

Timing & Frequency

Taltirelin is typically taken twice daily with or without food. Consistent timing is recommended to maintain stable plasma concentrations. Administer doses approximately 8-12 hours apart.

Cycle Guidance

For approved use in SCD, taltirelin is typically taken continuously without cycling. For experimental cognitive enhancement use, cycling may be considered to mitigate potential tolerance or receptor downregulation. A common cycle is 8-12 weeks on, followed by 4 weeks off.

Reconstitution Reference

Quick reference for reconstituting Taltirelin. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeN/A (Oral Tablet)
BAC Water VolumeN/A
Concentration & DrawN/A
StorageStore tablets at room temperature, away from moisture and light.
StabilityStable as per manufacturer expiration date when stored properly.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is the standard dosage of taltirelin for spinocerebellar degeneration?
The standard dosage for spinocerebellar degeneration, as approved in Japan, is 5 mg taken orally twice daily. This regimen has been shown to improve ataxia symptoms in clinical trials.
Can taltirelin be used for other conditions besides SCD?
Taltirelin is sometimes used off-label for other types of cerebellar ataxia. It is also being explored experimentally for cognitive enhancement purposes, although more research is needed to validate its efficacy and safety in these applications.
Are there any specific timing considerations for taking taltirelin?
It is recommended to take taltirelin twice daily, approximately 8-12 hours apart, to maintain stable plasma concentrations. Consistent timing with or without food can help optimize its effects.
How long does it take to see results from taltirelin?
In clinical trials for SCD, improvements in ataxia symptoms were typically observed within several weeks of starting taltirelin. However, individual responses may vary.

Last updated: 2026-02-19